ESC Professional Premium Access

The triglyceride-glucose index might be a better indicator for predicting poor cardiovascular outcomes in chronic coronary syndrome

Congress Presentation

About the speaker

Doctor Duygu Inan

Basaksehir Cam and Sakura City Hospital, Istanbul (Türkiye)
4 presentations
1 follower

6 more presentations in this session

Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?

Speaker: Doctor K. Overgaard (Svendborg, DK)

Thumbnail

Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry

Speaker: Doctor V. Ritsinger (Stockholm, SE)

Thumbnail

Vessel-oriented cardiovascular events in patients with diabetes undergoing intracoronary physiology-guided revascularization

Speaker: Doctor S. Sgreva (Galway, IE)

Thumbnail

Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention

Speaker: Doctor S. Moriya (Tokyo, JP)

Thumbnail

Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies

Speaker: Doctor F. Moroni (Charlottesville, US) Doctor A. Abbate (Charlottesville, US)

Thumbnail

Access the full session

Diabetes and stable coronary artery disease

Speakers: Doctor D. Inan, Doctor K. Overgaard, Doctor V. Ritsinger, Doctor S. Sgreva, Doctor S. Moriya...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by